Utilizing PI3K inhibitors as adjuvants in combination with antibiotics for these infections would eliminate intracellular bacteria (Oghumu and Satoskar, 2013; Kimmey and Stallings, 2016) to allow more effective host bacterial clearance and antibiotic treatment (Cano et al., 2015). The gene discussed is PIK3CD; the disease is infection.